October 27, 2026

Do Omega-3 Fats Protect Muscle? What Trials Show About Fish Oil, Muscle Protein Synthesis, and Disuse

By Dr. Zakira Naureen, Associate Professor, University of Nizwa
Nutrition Muscle Health Supplements

In Simple Terms

  • Will taking fish oil actually build or protect my muscle, or is it just marketing?
  • If I am stuck sitting still because of injury, study, or a desk job, can omega-3 slow the muscle I lose?
  • Is it worth the cost if I already train and eat enough protein?
  • What do we still not know for people carrying extra body fat?

Fish oil is one of the most widely sold supplements in the world, and muscle health is now among its advertised benefits. For young adults who are worried about losing muscle while carrying extra fat, the claim is tempting: a daily capsule that supposedly helps muscle respond to food and exercise. The honest picture is more mixed. Omega-3 fats do change how muscle cells behave, and a few small trials show real effects, but large reviews find little change in muscle size, and nobody has yet tested this properly in people with sarcopenic obesity. This article walks through what the trials actually measured so you can judge the claim for yourself.

The mechanism: how omega-3 fats could reach muscle

The two main marine omega-3 fats are EPA and DHA. When you take them regularly, they are built into the membranes that surround every muscle cell and the structures inside it. A 2023 narrative review in Nutrients by Taheri, Chilibeck, and Cornish describes several proposed routes. Omega-3 may make muscle cells more responsive to the signals that switch on protein building (the mTOR pathway), may help mitochondria, the cell's energy units, work better, and may calm low grade inflammation. The review is careful to say that much of this comes from cell and animal work, and that human findings do not yet confirm every step.

This matters for sarcopenic obesity because excess fat tissue releases inflammatory signals and can make muscle less responsive to protein, a process we describe in our posts on fat and muscle signaling and on insulin resistance and muscle protein synthesis. If omega-3 fats could improve the muscle response to a meal, they might partly counter that problem. That is the hope. The question is whether trials show it.

Evidence 1: a sharper response to protein in older adults

Gordon Smith and colleagues reported a randomized, placebo controlled trial in the American Journal of Clinical Nutrition (2011). Sixteen healthy adults aged 65 or older were assigned to 8 weeks of 4 g per day of prescription omega-3 (1.86 g EPA and 1.50 g DHA) or an equal amount of corn oil. Resting muscle protein synthesis did not change. But when the team infused amino acids and insulin to mimic a meal, the rise in synthesis was larger after omega-3 (an increase of 0.031 percent per hour above resting, compared with 0.009 before supplementation), while corn oil changed nothing. Signaling through p70s6k, a step downstream of mTOR, was also higher, and mTOR itself showed only a trend.

This is a mechanistic study, not a muscle growth study. There were only 7 or 8 people per group, the volunteers were healthy, not obese, and inactive, muscle mass and function were not followed, and the product was supplied by the manufacturer. It shows that the idea is biologically plausible. It does not show that muscle gets bigger or stronger.

Evidence 2: softening muscle loss during disuse in young women

Young adults are the focus of our research, so a trial in this group is especially relevant. Chris McGlory and colleagues (The FASEB Journal, 2019) gave 20 healthy young women (average age 22, BMI 23) either 5 g per day of omega-3 fats or an equal amount of sunflower oil for 4 weeks. They then immobilized one leg for 2 weeks. Thigh muscle volume fell by 14 percent in the control group but by 8 percent in the omega-3 group, and by the end of the recovery period the omega-3 group had returned to its starting size while the control group had not. Rates of myofibrillar protein synthesis, the building of the contractile proteins, were higher with omega-3 at all time points.

A companion analysis of the same study by Paolo Miotto and colleagues (The FASEB Journal, 2019) found that omega-3 also prevented the fall in mitochondrial respiration and mitochondrial protein content that occurred in the control group during immobilization. Together, these papers suggest omega-3 may be most useful when muscle is under stress from inactivity, which is relevant to injury, illness, or long sedentary stretches. Our posts on anabolic resistance after inactivity and prolonged sitting explain why inactivity is a risk factor in its own right.

The caveats are important. The dose of 5 g per day is well above what most people take, the sample was 20 women, the exposure was complete limb immobilization rather than ordinary sitting, and none of the women had overweight or low muscle mass.

Evidence 3: when you already train or are losing weight

Does the benefit persist when people are exercising and eating well? A randomized trial by Philpott and colleagues (Frontiers in Nutrition, 2019) tested 4 g per day of fish oil derived omega-3 against a placebo in 20 resistance trained young men (average age 23) during 2 weeks of calorie restriction to 60 percent of usual intake. Losses of body mass, fat free mass, and fat mass were similar in both groups. One strength measure, the one repetition maximum for the non-dominant leg extension, rose by about 6 percent with fish oil, but other strength outcomes did not differ, and the authors concluded any strength benefit was not linked to a change in lean mass.

This is a useful reality check for anyone hoping omega-3 will prevent the lean mass loss that comes with dieting. In well trained young men over a short period, it did not. Protein intake and resistance training remain the better supported tools, as discussed in our posts on protein during a calorie deficit and resistance training volume.

Evidence 4: the pooled picture across trials

The widest view comes from Stephen Cornish and colleagues (Nutrients, 2022), who combined 16 randomized studies with 2,438 adults aged 55 and older. Omega-3 supplementation did not change lean tissue mass (standardized mean difference 0.09, 95 percent CI minus 0.10 to 0.28), whether given alone or alongside resistance exercise. It did improve lower body strength (0.54, 0.33 to 0.75), and some performance tests, such as the timed up and go test. However, several results lost significance when studies at high risk of bias were removed, the benefit was bigger without exercise than with it, heterogeneity was high for some outcomes, and doses ranged from about 0.2 g to 5 g per day with durations from 6 weeks to 36 months.

Put plainly, the best available pooled evidence says omega-3 might help leg strength modestly in older adults, but it does not reliably add muscle. These are older adults, not young adults, and the results should not be stretched beyond that group.

What this means for sarcopenic obesity and young adults

Weighing the evidence, a few practical points follow:

  • Omega-3 is not a substitute for protein, resistance training, or sleep. None of the trials suggest it replaces them, and the pooled data show little added effect on lean mass.
  • It may be most relevant during periods of forced inactivity, such as a cast, bed rest, or a long illness, where the young women's trial showed protection. This is a hypothesis to discuss with a clinician, not a proven treatment.
  • Food first is a reasonable approach. Oily fish such as sardines, mackerel, or salmon provides EPA and DHA along with protein, and fits well with the nutrition steps in our complete guide for young adults. Supplements used in trials were often at high doses, so higher doses are not automatically safer. Anyone taking blood thinners or with a bleeding disorder should check with a clinician first.
  • Be sceptical of claims that fish oil will reverse sarcopenic obesity. No trial has shown that.

Limitations and open questions

Most mechanistic and disuse trials have fewer than 25 participants and last weeks, not years. The only large pooled analysis is in older adults, and its findings shift depending on which studies are included. Supplement types, doses, and control oils vary, and some control oils may themselves influence results. The Taheri review notes that human studies are not specific to obesity or sarcopenic obesity, and its obesity evidence comes from rodents, where results were inconsistent: some ALA rich oils improved lean mass in mice, while a very high flaxseed diet worsened insulin sensitivity in rats. Nothing is known about omega-3 effects on muscle in young Gulf populations, whose diets, vitamin D status, and activity patterns differ from the Western groups studied. A well designed trial in young adults with excess fat and low muscle quality, combining measures of muscle mass, strength, and muscle fat, would answer the question directly.

This post is for general education and is not medical advice. Please speak with a qualified healthcare provider before starting any supplement, especially if you take medication or have a medical condition.

References

← Back to all posts